<0> MedImmune to Exhibit at 2013 BIO International Convention, booth 3344, Apr 22 - 25, 2013, in Chicago IL, US </0>
MedImmuneTracy Rossin, 301-398-1468
MedImmune is the worldwide biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. MedImmune has approximately 2,500 employees globally, with its headquarters located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centers. For more information, please visit .